Exact Mass: 722.2322928
Exact Mass Matches: 722.2322928
Found 80 metabolites which its exact mass value is equals to given mass value 722.2322928
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Kansuinine B
Kansuinine B is a benzoate ester. Kansuinine B is a natural product found in Euphorbia kansui with data available.
Citbismine D
C40H38N2O11 (722.2475478000001)
Citbismine D is found in citrus. Citbismine D is an alkaloid from roots of Marsh grapefruit (Citrus paradisi). Alkaloid from roots of Marsh grapefruit (Citrus paradisi). Citbismine D is found in citrus.
Formononetin 7-O-(2,6-di-O-(E-p-coumaroyl)glucoside)
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate
[(2S,3R,4R,5S,6S)-2-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-6-methyloxan-3-yl] (E)-3-phenylprop-2-enoate
5-O-beta-D-Glucosylluteoliflavan-(4->8)-eriodictyol
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-2,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
jaspamide D
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.
24-alpha-D-glucuronopyranosyl-1,4-beta-D-xylotetraose
O-beta-D-xylopyranosyl-(1<*>4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl>-(1<*>3)-O-beta-D-xylopyranosyl-(1<*>4)-D-xylopyranose
aeruginosin DA722|D-o,o-di-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine
6-O-alpha-L-(2-O-trans-cinnamoyl-3-O-isovaleryl)rhamnopyranosylcatalpol|gmelinoside M
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-3,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
(2S)-5,7,5-trihydroxyflavanone 2-O-beta-D-4,6-O-diacetylglucopyranosyl-(1->3)-alpha-L-2-O-acetylrhamnopyranoside
jaspamide G
C36H43BrN4O7 (722.2314948000001)
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.
C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,3-Di-O-acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({2,4-Di-O-acetyl-6-deoxy-3-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
C34H42O17_(1aS,1bS,2S,5aR,6S,6aS)-6-({3,4-Di-O-acetyl-6-deoxy-2-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_6.1\\%
[(2S,3S,4R,5R,6S)-6-[[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl]oxy]-4,5-diacetyloxy-2-methyloxan-3-yl] (E)-3-phenylprop-2-enoate_major
Citbismine D
C40H38N2O11 (722.2475478000001)
2-[3-[1,1-Dimethyl-3-(4-sulfobutyl)-1,3-dihydro-benzo[e]indol-2-ylidene]-propenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt
C39H43N2NaO6S2 (722.2460098000001)
Obicetrapib
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
(R)-(+)-5,5-Bis[di(3,5-xylyl)phosphino]-4,4-bi-1,3-benzodioxole,min.98(R)-DM-SEGPHOS
Brostallicin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
(+)-Jasplakinolide W
C36H43BrN4O7 (722.2314948000001)
A cyclodepsipeptide isolated from Jaspis splendens.
jaspamide B
C36H43BrN4O7 (722.2314948000001)
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it exhibits anti-tumour activity.
1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
C37H46N4O7S2 (722.2807766000001)
1-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-(thiophen-2-ylsulfonylamino)-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
C37H46N4O7S2 (722.2807766000001)
5-[(1S,2R)-5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1,2-dihydrofuro[2,3-c]acridin-1-yl]-6,10-dihydroxy-11-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one
C40H38N2O11 (722.2475478000001)
6-({8-[3,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-1-benzopyran-7-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4R,5S)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate
[(3S,5S,6S)-3,4,5-triacetyloxy-6-[(3R,4S,5R)-1,2,4,5,6-pentaacetyloxyhexan-3-yl]oxyoxan-2-yl]methyl acetate
Naloxonazine (dihydrochloride)
C38H44Cl2N4O6 (722.2637744000001)
Naloxonazine dihydrochloride is a specific μ-opioid receptor antagonist with an IC50 of 5.4 nM. Naloxonazine dihydrochloride also shows anti-leishmanial activity[1][2][3].
NGR peptide (Trifluoroacetate)
C22H37F3N10O10S2 (722.2087538000001)
NGR peptide Trifluoroacetatecontaining the Asn-Gly-Arg (NGR) motif. NGR peptide Trifluoroacetate binds to APN/CD13. NGR peptide Trifluoroacetate is directly conjugated to imaging agents that can be used for tumor imaging[1][2].
(1s,3r,4s,6s,9r,10s,12r,13s,14r,15s,16s)-14,16-bis(acetyloxy)-12-(benzoyloxy)-1,9,15-trihydroxy-3,7,7,15-tetramethyl-11-methylidene-2,8-dioxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-10-yl benzoate
(1s,2s,4s,7r,9r,11s,13r,14s,15r,16s,17r)-15-(acetyloxy)-4,14-dihydroxy-2,14,17-trimethyl-3-oxo-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadecan-16-yl 2h-1,3-benzodioxole-5-carboxylate
2',12',14',16'-tetrakis(acetyloxy)-9'-[(acetyloxy)methyl]-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-15'-yl 3-methylbutanoate
4,22-dimethyl (1s,4s,5r,6s,7r,8r,10s,14s,16r,18s,19r,22s,23r,25s,26r)-23-(acetyloxy)-7,14-dihydroxy-4-methoxy-6-methyl-25-[(2-methylbutanoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4,22-dicarboxylate
7-[(2-bromo-1h-indol-3-yl)methyl]-6,12-dihydroxy-4-(4-hydroxyphenyl)-8,10,13,17,19-pentamethyl-15-methylidene-1-oxa-5,8,11-triazacyclononadeca-5,11-diene-2,9,16-trione
C36H43BrN4O7 (722.2314948000001)